AU8738375A - Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone - Google Patents

Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone

Info

Publication number
AU8738375A
AU8738375A AU87383/75A AU8738375A AU8738375A AU 8738375 A AU8738375 A AU 8738375A AU 87383/75 A AU87383/75 A AU 87383/75A AU 8738375 A AU8738375 A AU 8738375A AU 8738375 A AU8738375 A AU 8738375A
Authority
AU
Australia
Prior art keywords
adminstration
pyridone
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU87383/75A
Other versions
AU508824B2 (en
Inventor
S. M Gadekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affiliated Medical Research Inc
Original Assignee
AFFILIATED MEDICAL RESEARCH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/530,684 external-priority patent/US3974281A/en
Application filed by AFFILIATED MEDICAL RESEARCH Inc filed Critical AFFILIATED MEDICAL RESEARCH Inc
Publication of AU8738375A publication Critical patent/AU8738375A/en
Application granted granted Critical
Publication of AU508824B2 publication Critical patent/AU508824B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
AU87383/75A 1974-12-09 1975-12-09 Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone Expired AU508824B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USUS530,684 1974-12-09
US05/530,684 US3974281A (en) 1972-12-18 1974-12-09 5-Methyl-1-phenyl-2-(1H)-pyridone compositions and methods of use

Publications (2)

Publication Number Publication Date
AU8738375A true AU8738375A (en) 1977-06-16
AU508824B2 AU508824B2 (en) 1980-04-03

Family

ID=24114565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87383/75A Expired AU508824B2 (en) 1974-12-09 1975-12-09 Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone

Country Status (5)

Country Link
JP (1) JPS51128437A (en)
AU (1) AU508824B2 (en)
DK (1) DK555875A (en)
GB (1) GB1529960A (en)
ZA (1) ZA757570B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU687816B2 (en) * 1993-05-07 1998-03-05 Solomon B. Margolin Compositions and methods for reparation and prevention of fibrotic lesions

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02215719A (en) * 1989-02-15 1990-08-28 Yamauchi Akitomo Agent for repairing fibrosing lesion tissue and preventing fibrosing lesion
JP4542743B2 (en) * 2002-12-26 2010-09-15 Kdl株式会社 Solution pharmaceutical composition of pyridone derivatives
RS53599B1 (en) * 2005-05-10 2015-02-27 Intermune, Inc. Pyridone derivatives for modulating stress-activated protein kinase system
MX2007009796A (en) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel containing pirfenidone.
ES2913095T3 (en) * 2011-01-31 2022-05-31 Avalyn Pharma Inc Aerosolized pirfenidone and pyridone analog compounds and uses thereof
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
JP6501264B2 (en) 2012-07-24 2019-04-17 アヴァリン ファーマ インク. Compounds of analogues of pirfenidone and pyridone in aerosols and their use
NZ722927A (en) 2014-01-10 2022-07-29 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU687816B2 (en) * 1993-05-07 1998-03-05 Solomon B. Margolin Compositions and methods for reparation and prevention of fibrotic lesions

Also Published As

Publication number Publication date
GB1529960A (en) 1978-10-25
JPS51128437A (en) 1976-11-09
DK555875A (en) 1976-06-10
ZA757570B (en) 1977-07-27
AU508824B2 (en) 1980-04-03

Similar Documents

Publication Publication Date Title
IL47084A0 (en) Derivatives of pyridine
AU502752B2 (en) Pyridines
AU508824B2 (en) Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone
CA1029719A (en) Preparation of a-6-deoxy-5-hydroxytetracycline
AU509392B2 (en) Pyridinecarboxamides
JPS5219675A (en) 33iminoalkyll2*1h**pyridines preparation method and komposite thereof
AU506351B2 (en) Picolinic acid derivatives
AU1444476A (en) Preparation of 3-phenoxybenzaldehydes
HK46681A (en) 3-(alpha-iminobenzyl)-4-hydroxy-6-phenyl-1-methyl-2(1h)-pyridone
SU583362A1 (en) Furan-3-carbon amides of alpha-asparaginazes exhibiting antileukosis activity
SU576244A1 (en) Roller of endless-track vehicle-propelling means
AU509813B2 (en) Preparation of triazine-diones
SU600089A1 (en) Method of preparing dioxytetrachlormolybdates
AU476488B2 (en) Preparation of 6-deoxytetracyclines
AU518493B2 (en) Nicotinic derivatives of estriol
JPS51128973A (en) Preparation method of aminopyridine
AU493262B2 (en) New derivatives of pyridine
JPS527968A (en) 33phenyll4*1h*pyridone and pyridinthiones and salts thereof
CA1025864A (en) Preparation of 2-amino-4-hydroxypyrimidines
AU488288B2 (en) 6-hydrazino-2, 3, 5-trihalo-4-alkythio pyridines and method of preparing same
NZ185126A (en) 3-( -iminobenzyl)-4-hydroxy-6-phenyl-1-methyl-2(1h)-pyridone and pharmaceutical compositions
EG11860A (en) Preparation of novel substituted pyridines
AU471466B2 (en) Penam compounds and preparation thereof
AU1392276A (en) Compounds for controlling coccidiosis and their preparation
AU482252B2 (en) 2-HYDROXYMETHYL-3-HYDROXY-6-(1-HYDROXY-2-t BUTYLAMINOETHYL) PYRIDINE PREPARATION AND INTERMEDIATE COMPOUNDS